Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.

Trial confirms that oral semaglutide lowers cardiovascular risk in type 2 diabetes, regardless of SGLT2i use. Read more!

In its first quarter 2025 investor letter, ClearBridge Small Cap Growth Strategy emphasized stocks such as Hims & Hers Health, Inc. (NYSE:HIMS). Hims & Hers Health, Inc. (NYSE:HIMS) offers a ...

Compounded semaglutide has not gone through the same review process as FDA-approved drugs, so it is unclear how safe or effective these products are. It’s important to get a prescription for ...

In India, there were 32 centres and 788 people enrolled. Semaglutide was initially approved in June 2021 for chronic weight management in those with obesity or overweight and at least one weight ...

Many treatments are available, and with the popularity of online and mail-order services in recent years, two leaders are BlueChew and Hims. Both companies offer different ED treatments and a ...

LifeMD used to be at a disadvantage to HIMS with its much bigger membership and its own cheap compounded weight management products. However, the end of the scarcity of semaglutide (Ozempic and ...